Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 10.06.2026 FTFX IE00BD5HBQ97 63,402.00 USD 1,695,809.88 26.747  ...

AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike (NASDAQ: CRWD) today announced it has been named the Growth and Innovation Leader in the 2026 Frost Radar™: Cloud and Application Runtime Security for the second consecutive time, scoring highest of all vendors evaluated. As AI workloads and frontier model risk expose the limits of posture-only defense, organizations are turning to runtime-first security on the CrowdStrike Falcon® platform to stop breaches in real time. Frost & Sullivan highlighte...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Global Water UCITS ETF 10.06.2026 H2O LN IE000Q8F0M81 600,002.00 USD 11,666,050.53 19.443  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF - September 10.06.2026 MSEP.LN IE0009DRFET8 50,002.00 USD 1,383,059.92 27.660  ...

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), today announced that it will participate in the TD Cowen Medical Devices Emerging Growth Call Series at 12:00pm ET on June 18, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, EVP, Chief Financial Officer and David Horsley, SVP, Innovation, will take part in the discussion. To register or access the audio-only webcast, visit the Events & Presentations secti...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved Guardant360® CDx as a companion diagnostic (CDx) for Boehringer Ingelheim’s HERNEXEOS® (zongertinib tablets), the first targeted therapy for adults with HER2 (ERBB2)-mutant advanced non-small cell lung cancer (NSCLC) as an initial treatment option. The approval enables Guardant360 CDx, a liquid biopsy test tha...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that six abstracts in narcolepsy and idiopathic hypersomnia have been accepted for poster presentation at SLEEP 2026, the 40th annual meeting of the Associated Professional Sleep Societies (APSS), which will be held June 14 – 17 in Baltimore, MD. The poster presentation details are as follows: Abstract Title Poster Presentation Session Treatment with Pitolisant in Subgroups of Adults with...

ALPHARETTA, Ga.--(BUSINESS WIRE)--Agilysys, Inc. (Nasdaq: AGYS), a leading global provider of hospitality technology solutions and services, today announced that it will present three educational sessions at HITEC 2026, taking place June 15-18 in San Antonio, Texas. Led by Agilysys Senior Vice President of Product Strategy and CMO Frank Pitsikalis and Vice President, Sales Engineering, Thor Hansen, the sessions will examine how hospitality organizations are using connected data, created by the...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Rising Dividend Achievers UCITS ETF 10.06.2026 RDVY LN IE000K5F6EL4 900,002.00 USD 21,609,969.95 24.011  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - June 10.06.2026 QJUN.LN IE000HFBJ0U0 3,750,002.00 USD 84,550,996.60 22.547  ...